- Home
- DLTR vs TEVA Comparison
DLTR vs TEVA Comparison
Compare DLTR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTR
- TEVA
- Stock Information
- Founded
- DLTR 1986
- TEVA 1901
- Country
- DLTR United States
- TEVA Israel
- Employees
- DLTR N/A
- TEVA N/A
- Industry
- DLTR Department/Specialty Retail Stores
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- DLTR Consumer Discretionary
- TEVA Health Care
- Exchange
- DLTR Nasdaq
- TEVA Nasdaq
- Market Cap
- DLTR 20.2B
- TEVA 21.2B
- IPO Year
- DLTR 1995
- TEVA N/A
- Fundamental
- Price
- DLTR $106.29
- TEVA $25.32
- Analyst Decision
- DLTR Buy
- TEVA Strong Buy
- Analyst Count
- DLTR 20
- TEVA 7
- Target Price
- DLTR $104.39
- TEVA $25.86
- AVG Volume (30 Days)
- DLTR 4.1M
- TEVA 12.1M
- Earning Date
- DLTR 12-03-2025
- TEVA 11-05-2025
- Dividend Yield
- DLTR N/A
- TEVA N/A
- EPS Growth
- DLTR N/A
- TEVA N/A
- EPS
- DLTR N/A
- TEVA 0.62
- Revenue
- DLTR $18,551,100,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- DLTR $12.44
- TEVA $4.11
- Revenue Next Year
- DLTR $5.74
- TEVA $0.40
- P/E Ratio
- DLTR N/A
- TEVA $38.84
- Revenue Growth
- DLTR 78.90
- TEVA 0.02
- 52 Week Low
- DLTR $60.49
- TEVA $12.47
- 52 Week High
- DLTR $118.06
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- DLTR 62.80
- TEVA 80.51
- Support Level
- DLTR $100.14
- TEVA $23.61
- Resistance Level
- DLTR $107.48
- TEVA $25.00
- Average True Range (ATR)
- DLTR 3.30
- TEVA 0.76
- MACD
- DLTR 0.73
- TEVA 0.54
- Stochastic Oscillator
- DLTR 86.06
- TEVA 99.23
About DLTR Dollar Tree Inc.
Dollar Tree operates discount stores across the United States and Canada, with over 8,800 shops under its namesake banner. About 50% of Dollar Tree's sales in fiscal 2024 were consumables (including food, health and beauty, and cleaning products), around 45% variety items (including toys and homewares), and 5% seasonal items. Dollar Tree sells most of its merchandise at the $1.25 price point and positions its stores in well-populated suburban markets. The retailer has agreed to sell Family Dollar (with about 7,000 stores) to private equity investors for $1 billion.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.